Loading...
Long‐term cardiovascular effects of vandetanib and pazopanib in normotensive rats
Vandetanib and pazopanib are clinically available, multi‐targeted inhibitors of vascular endothelial growth factor (VEGF) and platelet‐derived growth factor (PDGF) receptor tyrosine kinases. Short‐term VEGF receptor inhibition is associated with hypertension in 15%‐60% of patients, which may limit t...
Na minha lista:
| Udgivet i: | Pharmacol Res Perspect |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543457/ https://ncbi.nlm.nih.gov/pubmed/31164986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.477 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|